How to transfer my Strattera prescription to Texas

If you’re exploring ADHD treatment options and wondering whether telehealth can help you access non-stimulant medications like Strattera, you’re not alone. Millions of Americans have turned to virtual care for mental health support, and the landscape of ADHD treatment has evolved significantly—especially in the wake of recent regulatory changes.

The short answer is yes—you can typically get ADHD non-stimulant medications prescribed through telehealth in most states. But as with many healthcare questions, the full answer involves understanding federal regulations, state-specific rules, and what to expect from a legitimate telehealth provider.

Understanding Non-Stimulant ADHD Medications

What Are Non-Stimulant ADHD Medications?

Non-stimulant medications offer an alternative approach to managing ADHD symptoms. Unlike stimulant medications such as Adderall or Ritalin, these medications work differently in the brain and aren’t classified as controlled substances by the DEA.

Strattera (atomoxetine) is the most commonly prescribed non-stimulant ADHD medication. It’s FDA-approved for children age 6 and older and adults, and works by affecting norepinephrine, a brain chemical that helps with attention and impulse control.

Key Advantages of Non-Stimulant Options

Non-stimulant medications like Strattera offer several benefits that make them particularly well-suited for telehealth prescribing:

• Not a controlled substance – Strattera carries no DEA restrictions, meaning providers can prescribe it with greater flexibility
• Lower abuse potential – Since it’s not habit-forming, there’s no risk of dependency or misuse
• Flexible prescribing – Providers can write prescriptions for 90-day supplies with multiple refills, unlike stimulants which require monthly prescriptions
• Fewer regulatory hurdles – State and federal telehealth restrictions that apply to controlled substances don’t affect non-stimulants

That said, non-stimulants typically take 4-6 weeks to reach full effectiveness, whereas stimulants often work within hours. Your provider will help determine which option best fits your needs.

Free consultations available with select providers only.

Get a free consultation

And find an affordable, caring specialist.

Find a provider

Free consultations available with select providers only.

Federal Telehealth Rules: What You Need to Know

The Current Regulatory Landscape

The COVID-19 pandemic dramatically changed telehealth prescribing rules. In March 2020, the DEA issued temporary flexibilities that allowed providers to prescribe controlled substances via telehealth without a prior in-person examination—a significant departure from the Ryan Haight Act of 2008, which previously required face-to-face visits.

As of December 2025, these flexibilities have been extended through December 31, 2025, marking the third temporary extension. The DEA has signaled that a fourth extension for 2026 is under review, though no final rule has been published yet.

Here’s what matters most for ADHD patients:

For Stimulant Medications (Schedule II controlled substances like Adderall, Ritalin):

• Currently allowed via telehealth through 12/31/2025 under the temporary waiver
• Providers must have proper DEA registration
• Future rules may require an in-person visit—stay informed

For Non-Stimulant Medications (like Strattera):

• No federal restrictions on telehealth prescribing—never have been
• The Ryan Haight Act’s in-person requirement only applies to controlled substances
• Strattera has always been prescribable via telehealth, even before the pandemic

What Happens If Federal Waivers Expire?

If the DEA’s temporary extensions expire without replacement regulations, the Ryan Haight Act’s in-person exam requirement would technically resume for controlled substances. However, this would not affect non-stimulant medications like Strattera.

The DEA is working on a proposed ‘Special Registration’ framework that could establish permanent telehealth pathways with additional safeguards, but this hasn’t been finalized as of early 2025.

State-by-State Telehealth Rules for ADHD Treatment

While federal rules set the baseline, individual states have their own telehealth regulations. Here’s what you need to know about key states:

States with Minimal Restrictions

California: Fully allows telehealth for ADHD treatment with no mandatory in-person visits for non-controlled medications. The state defines a telehealth examination as sufficient to establish a provider-patient relationship.

Illinois: Comprehensive telehealth laws with no in-person requirements. Illinois achieved full practice authority for nurse practitioners, making ADHD care widely accessible through virtual platforms.

Pennsylvania: Permanent telehealth laws in place since 2020 with no in-person mandate for ADHD medication prescribing.

States with Some Additional Requirements

Florida: Generally telehealth-friendly, though with specific rules for controlled substances. For ADHD specifically, Schedule II stimulants can be prescribed via telehealth when treating a ‘psychiatric disorder’—which includes ADHD. For non-stimulants like Strattera, there are no special restrictions. Florida does require providers to check the state’s Prescription Drug Monitoring Program (PDMP) before every controlled substance prescription.

Texas: Very supportive of telehealth for mental health conditions. However, nurse practitioners and physician assistants face limitations—they can only prescribe Schedule II medications (stimulants) in hospital or hospice settings. Physicians have no such restrictions. For non-stimulants, NPs and PAs can prescribe under their collaborative agreements.

New Hampshire: Recently modernized its approach in August 2025 by removing prior in-person requirements. Now requires only an annual follow-up evaluation (which can be conducted via telehealth) for controlled substance prescribing.

States with Stricter Requirements

New York: In May 2025, New York implemented a rule requiring an initial in-person medical evaluation before prescribing any controlled substance via telehealth. This affects stimulant medications but does not apply to non-controlled medications like Strattera, which can still be prescribed through telehealth without an in-person visit.

Alabama: One of the strictest states for telehealth. Alabama requires an in-person visit within 12 months if providing ongoing telehealth treatment. However, there’s an important exception: mental health services are exempt from this requirement. Since ADHD is a mental health condition, ongoing telehealth treatment should qualify for this exemption. Still, Alabama requires that for controlled substance prescriptions, a licensed medical professional must be physically present with the patient during the initial telehealth visit if there’s been no prior in-person exam.

Who Can Prescribe ADHD Medications via Telehealth?

Physicians (MD/DO)

Licensed physicians can prescribe both stimulant and non-stimulant ADHD medications via telehealth in all 50 states, provided they:

• Are licensed in the state where the patient is located
• Have appropriate DEA registration (for controlled substances)
• Follow standard diagnostic and prescribing practices

Nurse Practitioners and Physician Assistants

The authority of NPs and PAs to prescribe ADHD medications varies significantly by state:

Full Practice Authority States (Independent NP prescribing):

• New York, California, Illinois, New Hampshire, and over 20 other states allow NPs to prescribe both stimulants and non-stimulants independently after meeting experience requirements
• These NPs can diagnose ADHD and manage treatment without physician oversight

Collaborative Practice States:

• Florida, Pennsylvania, and others require NPs/PAs to have a collaborative agreement with a physician
• The supervising physician’s delegation determines what medications the NP/PA can prescribe

Restricted States (Limited Schedule II authority):

• Texas: NPs/PAs cannot prescribe Schedule II stimulants in regular outpatient settings—only in hospitals or hospice care. However, they can prescribe non-stimulants like Strattera under supervision.
• Georgia: NPs cannot prescribe Schedule II controlled substances at all, even with physician delegation. They can prescribe Schedule III-V medications and non-controlled drugs like Strattera with a collaborative agreement.

What This Means for You: If you’re considering telehealth ADHD treatment with a nurse practitioner, verify that your state allows NP prescribing of your intended medication. Reputable telehealth platforms will only match you with appropriately credentialed providers licensed in your state.

What to Expect from a Telehealth ADHD Evaluation

Legitimate telehealth ADHD care is comprehensive—not a quick online quiz. Here’s what a proper evaluation involves:

Initial Assessment

Your provider will conduct a thorough evaluation that typically includes:

Symptom History: Detailed questions about attention difficulties, hyperactivity, impulsivity, and how symptoms affect different areas of your life (work, relationships, daily tasks)

Childhood History: ADHD symptoms typically begin in childhood. Providers may ask about school reports, old report cards, or speak with family members who knew you as a child

Medical History: Complete review of your physical health, other mental health conditions, medications, substance use history, and family history

Standardized Assessments: Many providers use validated rating scales and questionnaires aligned with DSM-5 diagnostic criteria

Differential Diagnosis: Ruling out other conditions that can mimic ADHD (anxiety, depression, sleep disorders, thyroid issues)

What Documentation You May Need

Be prepared to provide:

• Photo ID and insurance information
• List of current medications and past treatments
• Medical records if available
• Contact information for your primary care provider (for care coordination)

Some telehealth platforms request childhood records or ask you to have a family member corroborate symptoms to strengthen the diagnostic picture.

Red Flags That May Require In-Person Evaluation

Telehealth providers must screen for situations where remote care may not be appropriate:

• Uncontrolled high blood pressure or significant cardiovascular disease
• Active substance abuse or recent history of stimulant misuse
• Severe psychiatric symptoms requiring immediate intervention
• Unclear diagnosis requiring more extensive testing
• Patient preference for in-person care

If any of these apply, your telehealth provider may recommend an in-person specialist consultation before proceeding with treatment.

The Klarity Health Approach to Telehealth ADHD Care

At Klarity Health, we understand that accessing quality ADHD care shouldn’t be complicated. Our platform connects you with licensed providers—physicians and nurse practitioners—who are experienced in diagnosing and treating ADHD in adults.

What Sets Klarity Apart

Provider Availability: We prioritize getting you seen quickly. Many patients can schedule an appointment within days, not weeks or months like traditional psychiatry.

Transparent Pricing: Whether you use insurance or pay out-of-pocket, you’ll know the cost upfront. We accept most major insurance plans and offer competitive self-pay rates.

Both Insurance and Cash Pay Options: Not everyone has insurance that covers mental health care, and some prefer to pay directly. We accommodate both.

Comprehensive Care: Your Klarity provider won’t just write a prescription. They’ll work with you to develop a complete treatment plan, monitor your progress through follow-up visits, and adjust your care as needed.

The Klarity Process

1. Complete a Brief Online Assessment: Share your symptoms and medical history through our secure platform
2. Schedule Your Video Visit: Meet with a licensed provider via secure video
3. Receive Your Treatment Plan: If appropriate, your provider can send prescriptions electronically to your pharmacy the same day
4. Ongoing Support: Regular follow-ups ensure your treatment is working and address any concerns

Klarity providers can prescribe both stimulant and non-stimulant ADHD medications where legally permitted, always following the highest standards of care and applicable state regulations.

Prescription Monitoring and Safety Considerations

PDMP Requirements by State

Many states require providers to check Prescription Drug Monitoring Programs before prescribing controlled substances. These databases track controlled medication prescriptions to prevent misuse and identify potential problems.

Even when not legally mandated, responsible providers typically review a patient’s controlled substance history as part of comprehensive care.

Safety Measures in Telehealth ADHD Prescribing

Following controversies with some telehealth startups in 2022-2023, the industry has significantly strengthened safety protocols:

Enhanced Screening: More thorough patient evaluations to ensure accurate diagnosis and appropriate treatment

Regular Follow-Ups: Monitoring for medication effectiveness, side effects, and any signs of misuse

Treatment Agreements: Some providers use signed agreements outlining expectations for controlled substance prescriptions

Care Coordination: Communication with primary care providers and other specialists

Drug Testing: Periodic urine drug screens may be required for stimulant prescriptions

These measures protect patients and help ensure continued access to legitimate telehealth ADHD care.

Comparing Stimulant vs. Non-Stimulant Options

When Non-Stimulants Make Sense

Your provider might recommend starting with or switching to a non-stimulant like Strattera if:

• You have a personal or family history of substance abuse
• Stimulants caused unacceptable side effects (severe insomnia, anxiety, elevated blood pressure)
• You have certain heart conditions that make stimulants risky
• You prefer a medication without abuse potential
• You have co-occurring anxiety or depression (Strattera may help both)
• You need more prescribing flexibility (longer supplies, easier refills)

Common Questions About Telehealth ADHD Prescriptions

Will my pharmacy fill a telehealth prescription?

Yes. Electronic prescriptions from licensed telehealth providers are treated the same as in-person prescriptions. Your pharmacist won’t know whether your visit was virtual or in-person. Most major pharmacy chains routinely fill telehealth prescriptions.

In 2023, some pharmacies increased scrutiny of controlled substance prescriptions from certain telehealth platforms following regulatory investigations. Using an established, reputable telehealth service like Klarity and maintaining a consistent pharmacy relationship helps avoid any issues.

How long does a Strattera prescription last?

Since Strattera isn’t a controlled substance, your provider can write prescriptions for up to a 90-day supply with multiple refills (up to 5 refills or 11 months total). This is more convenient than stimulants, which require a new prescription every 30 days.

Can I use telehealth if I move to a different state?

Healthcare providers must be licensed in the state where you’re located during the appointment. If you move, you’ll need to find a provider licensed in your new state. Many telehealth platforms operate in multiple states, so you may be able to stay with the same company but see a different provider.

Notify your current provider about your move so they can help coordinate the transition and ensure you don’t have a gap in care.

What if I need an in-person evaluation?

If your telehealth provider determines you need in-person care—perhaps due to complex medical issues or unclear diagnosis—they’ll provide a referral. Some situations genuinely require face-to-face assessment, physical examination, or specialized testing that can’t be done remotely.

Responsible telehealth providers recognize their limitations and prioritize your safety over simply prescribing medication.

Are online ADHD prescriptions legitimate?

Yes—when prescribed by licensed, qualified providers following proper diagnostic protocols. However, you should avoid services that:

• Guarantee a prescription before evaluating you
• Require only a brief questionnaire with no video visit
• Don’t verify your identity or check your medical history
• Promise medication without discussing risks, alternatives, or non-medication strategies

Legitimate telehealth ADHD care follows the same standards as in-person treatment. The visit happens via video instead of in an office, but the clinical rigor should be identical.

Tips for Successful Telehealth ADHD Treatment

Before Your Appointment

1. Find a quiet, private space with good internet connection and lighting
2. Test your video/audio beforehand to avoid technical difficulties
3. Gather your medical history: List of medications, past treatments, other conditions
4. Write down your symptoms and specific examples of how ADHD affects your daily life
5. Prepare questions about treatment options, side effects, and follow-up care

During Your Appointment

1. Be honest and thorough: Your provider can only help if they have accurate information
2. Don’t minimize symptoms: Many people downplay their struggles—be specific about challenges
3. Ask about non-medication strategies: Medication works best combined with therapy, coaching, or skills training
4. Discuss your preferences: Share your concerns about specific medications
5. Clarify next steps: Make sure you understand the treatment plan and follow-up schedule

After Getting Prescribed

1. Take medication as directed: Don’t adjust doses on your own
2. Track your response: Note improvements in symptoms and any side effects
3. Attend follow-up appointments: These are crucial for adjusting treatment
4. Communicate changes: Contact your provider if something isn’t working or you experience problems
5. Practice good medication management: Set reminders, use a pill organizer, keep track of refills

With Strattera specifically, remember that it takes several weeks to reach full effectiveness. Don’t give up if you don’t notice changes immediately—stay in communication with your provider about your experience.

The Future of Telehealth ADHD Care

What’s Coming in 2026?

The regulatory landscape continues to evolve. Here’s what to watch:

DEA Regulations: The current telehealth flexibilities for controlled substances expire December 31, 2025. A fourth extension is anticipated but not guaranteed. The DEA may implement new permanent rules requiring periodic in-person visits for stimulant prescriptions.

State-Level Changes: More states are likely to either expand or clarify their telehealth rules. Texas is considering legislation (HB 1948) that would expand nurse practitioner authority to prescribe Schedule II medications in outpatient settings.

Congressional Action: Federal legislation like the TREATS Act could standardize telehealth prescribing rules across states and make temporary COVID-era flexibilities permanent.

Staying Informed

If you’re receiving telehealth ADHD treatment:

• Watch for communications from your telehealth provider about regulatory changes
• Don’t panic about potential rule changes—providers are actively working to ensure continuity of care
• Ask your provider about contingency plans if regulations require in-person visits
• Advocate for continued telehealth access by contacting your congressional representatives

When to Consider In-Person ADHD Care

Telehealth works wonderfully for many people, but in-person care may be preferable if you:

• Have complex medical or psychiatric conditions requiring close monitoring
• Need extensive diagnostic testing (neuropsychological assessment, etc.)
• Prefer face-to-face interaction with your provider
• Have unreliable internet access or technology barriers
• Are a child or teen (many telehealth platforms treat only adults)
• Have been asked by your telehealth provider to follow up in person

There’s no ‘wrong’ choice—the best care is the care that works for you.

Take the First Step Toward Better Focus

Living with untreated ADHD can affect every area of your life—work performance, relationships, self-esteem, and daily functioning. The good news? Effective treatment is more accessible than ever through telehealth.

Whether you’re exploring non-stimulant options like Strattera or considering all available treatments, Klarity Health makes it simple to connect with experienced providers who understand ADHD and can develop a personalized treatment plan.

Ready to get started? Visit Klarity Health to schedule your initial ADHD evaluation. Our licensed providers are available throughout the week, with appointments often available within days. We accept most insurance plans and offer transparent self-pay pricing—because getting help shouldn’t be complicated.

You deserve to experience what it feels like when your brain works with you instead of against you. Take that first step today.

Frequently Asked Questions

Can I get Strattera prescribed online without an in-person visit?

Yes. Strattera (atomoxetine) is not a controlled substance, so federal law doesn’t require an in-person examination before prescribing it via telehealth. Your provider will conduct a comprehensive video evaluation to diagnose ADHD and determine if Strattera is appropriate for you.

Do all states allow telehealth ADHD prescriptions?

All states allow telehealth for ADHD care, though specific rules vary. Some states like New York and Alabama have additional requirements for controlled substances, but non-stimulant medications like Strattera face minimal restrictions. Your telehealth provider will ensure they’re following all applicable state laws.

How much does telehealth ADHD treatment cost?

Costs vary depending on whether you use insurance or pay out-of-pocket. At Klarity Health, we provide transparent pricing upfront and accept most major insurance plans. Self-pay initial consultations typically range from $99-$199, with follow-ups often less expensive. Check with your specific telehealth provider for their pricing.

Will my insurance cover a telehealth ADHD evaluation?

Most insurance plans now cover telehealth visits at the same rate as in-person appointments, thanks to expanded parity laws. Check your specific plan’s mental health benefits. Klarity Health works with most major insurance carriers and can verify your coverage before your appointment.

How long until I get my medication after a telehealth visit?

If your provider prescribes medication during your visit, they’ll typically send the prescription electronically to your pharmacy the same day. You can often pick it up within hours (depending on pharmacy stock). For controlled stimulants, some pharmacies may need 1-2 days to order the medication.

What if Strattera doesn’t work for me?

Not everyone responds to the first ADHD medication tried. If Strattera isn’t effective after an adequate trial (typically 6-8 weeks), your provider can discuss alternatives—other non-stimulants, stimulant medications, or combination approaches. This is why regular follow-ups are important.

Can college students use telehealth for ADHD medication?

Yes. Many college students benefit from telehealth ADHD care. If you’re attending school in a different state than your home address, ensure your provider is licensed in the state where you’re physically located during appointments. Some colleges also have their own telehealth services.

References

1. DEA ‘Third Temporary Extension of COVID-19 Telemedicine Flexibilities for Prescription of Controlled Substances’ – Federal Register (via FierceHealthcare), November 2024. This official DEA ruling extended telehealth prescribing flexibilities for Schedule II-V controlled substances through December 31, 2025.

2. Sheppard Mullin Healthcare Law – ‘Telehealth and In-Person Visits: Tracking Federal and State Updates to Pandemic-Era Telehealth Exceptions’ – National Law Review, August 15, 2025. Comprehensive 50-state survey of telehealth regulations including detailed analysis of state-specific requirements for ADHD medication prescribing.

3. Medical News Today – ‘Is Strattera a controlled substance?’ – January 14, 2025. Medically reviewed article confirming that atomoxetine (Strattera) is not classified as a DEA controlled substance and explaining its non-habit-forming properties.

4. Center for Connected Health Policy (CCHP) – State Telehealth Laws: Online Prescribing – Accessed November 2025. Authoritative database of state-by-state telehealth prescribing requirements, including Florida’s Schedule II exceptions and Alabama’s in-person visit rules.

5. Texas Medical Board & Texas Board of Nursing – Scope of Practice Rules (via SingleAimHealth analysis), Updated December 9, 2025. Official guidance on nurse practitioner and physician assistant prescribing authority in Texas, specifically addressing Schedule II medication limitations.

This article is for informational purposes only and does not constitute medical advice. ADHD diagnosis and treatment should be provided by qualified healthcare professionals. Regulations mentioned are current as of December 17, 2025, and may change. Always verify current rules with your healthcare provider.

Source:

• https://www.fiercehealthcare.com/regulatory/dea-finalizes-one-year-extension-controlled-substance-prescribing-telehealth-punts-final#:~:text=The%20Drug%20Enforcement%20Administration%20,Federal%20Register%20on%20Friday%20night
• https://www.mwe.com/insights/dea-signals-extension-of-telemedicine-flexibilities-for-controlled-substance-prescribing-for-2026/#:~:text=visit,examination%20through%20December%2031%2C%202025
• https://www.mwe.com/insights/dea-signals-extension-of-telemedicine-flexibilities-for-controlled-substance-prescribing-for-2026/#:~:text=A%20new%20rule%20posted%20on,date%20of%20December%2031%2C%202025
• https://www.fiercehealthcare.com/regulatory/dea-finalizes-one-year-extension-controlled-substance-prescribing-telehealth-punts-final#:~:text=The%20%E2%80%9CThird%20Temporary%20Extension%20of,14
• https://www.medicalnewstoday.com/articles/drugs-is-strattera-a-controlled-substance#:~:text=Strattera%20,such%20as%20mental%20health%20issues
• https://www.sheppardhealthlaw.com/2025/08/articles/telehealth/telehealth-and-in-person-visits-tracking-federal-and-state-updates-to-pandemic-era-telehealth-exceptions/#:~:text=In%20late%202024%2C%20the%20U,prescribing
• https://www.rxagent.co/blog/telehealth-compliance-trap#:~:text=The%20,False%20Hope
• https://www.techtarget.com/virtualhealthcare/news/366616019/Telehealth-prescribing-flexibility-extended-through-2025#:~:text=Image%20filo%2FDigitalVision%20Vectors%20via%20G,The
• https://natlawreview.com/article/telehealth-and-person-visits-tracking-federal-and-state-updates-pandemic-era?amp=#:~:text=Extend%20natlawreview,before%20issuing%20a%20dangerous%20drug
• https://www.rxagent.co/blog/telehealth-compliance-trap#:~:text=,specifically%20for%20chronic%20pain%20treatment